Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-18
2006-04-18
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S009100, C514S010100, C514S011400, C514S163000, C514S183000, C514S186000, C514S210170, C514S282000, C514S315000, C514S327000, C514S329000, C514S330000, C514S371000, C514S372000, C514S423000, C514S449000, C514S450000, C514S867000, C514S974000, C424S653000, C424S725000, C424S776000
Reexamination Certificate
active
07030147
ABSTRACT:
Epothilone derivatives are co-administered with an antidiarrheal agent, e.g., a DPP-IV inhibitor, in the treatment of a proliferative disease.
REFERENCES:
patent: 5969145 (1999-10-01), Schinzer et al.
patent: 5977163 (1999-11-01), Li et al.
patent: 6040321 (2000-03-01), Kim et al.
patent: 6103487 (2000-08-01), Barnett et al.
patent: 6127390 (2000-10-01), deSolms et al.
patent: 6302838 (2001-10-01), O'Reilly et al.
patent: WO 01 92255 (2001-12-01), None
Altaha, Ramin et al., “Epothilones: A novel class of non-taxane microtubule-stabilizing agents,” Current Pharmaceutical Design, vol. 8(19), pp. 1707-1712 (2002).
Chen TianLing
Greeley Diane
Rothermel John David
Schran Horst F.
Jackson Oona A.
McNally Lydia T.
Novartis AG
Pak John
Stitzel David P.
LandOfFree
Combinations comprising an antidiarrheal agent and an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations comprising an antidiarrheal agent and an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations comprising an antidiarrheal agent and an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549664